PRAX
Praxis Precision Medicines, Inc.
-0.91 (-0.29%)308.08USD304K成交股數8.6B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | 0.00-100% | 0.00-100% | 0.00-100% | – | 302K-35% | 357K-54% | 431K | – | 468K | 781K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 69.4M | 78.0M | 65.8M | 63.0M | 60.8M | – | 41.9M | 27.3M | 27.0M | – | 17.3M | 25.6M |
| 銷售管理費用 | 27.5M | 27.9M | 12.6M | 13.1M | 13.9M | – | 15.3M | 10.6M | 15.3M | – | 8.7M | 10.1M |
| 營業利益 | −96.9M+30% | −106M | −78.4M+38% | −76.1M+103% | −74.7M+78% | – | −56.8M+123% | −37.5M+7% | −41.9M | – | −25.5M | −35.0M |
| 營業利益率 | – | – | – | – | – | – | -18,819.5% | -10,500.8% | -9,718.3% | – | -5,452.1% | -4,476.3% |
| 稅後淨利 | −83.7M+21% | −92.6M+58% | −73.9M+42% | −71.1M+118% | −69.3M+75% | −58.7M+118% | −51.9M+111% | −32.7M-5% | −39.6M | −26.9M | −24.6M | −34.3M |
| 淨利率 | – | – | – | – | – | – | -17,188.7% | -9,153.2% | -9,177.0% | – | -5,263.2% | -4,393.3% |
| 稀釋 EPS | -2.87-13% | -3.20 | -3.36+22% | -3.31+90% | -3.29+16% | – | -2.75+1% | -1.74-76% | -2.84 | – | -2.72 | -7.38 |
| 稀釋股數 | 29.1M | 28.9M | 22.0M | 21.5M | 21.1M | – | 18.9M | 18.8M | 13.9M | – | 9.0M | 4.6M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 475M | 536M | 150M | 157M | 166M | 215M | 169M | 145M | 152M | 81.3M | 101M | 124M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 1.4B | 1.5B | 396M | 453M | 479M | 483M | 416M | 441M | 250M | 87.9M | 107M | 133M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 49.1M | 50.2M | 52.9M | 48.6M | 39.5M | 37.7M | 33.6M | 22.0M | 20.7M | 18.3M | 20.0M | 27.9M |
| 股東權益 | 1.3B | 1.4B | 344M | 404M | 439M | 445M | 383M | 419M | 230M | 69.7M | 86.8M | 106M |
| 負債比 | 3.5% | 3.4% | 13.3% | 10.7% | 8.3% | 7.8% | 8.1% | 5.0% | 8.3% | 20.8% | 18.7% | 20.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −86.2M | – | – | −53.0M+154% | – | – | – | −20.9M | – | – | – |
| 資本支出 | – | 62K | – | – | 0.00 | – | – | – | – | – | – | – |
| 自由現金流 | – | −86.2M | – | – | −53.0M | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | -100.0% | −303M | –% | -13.48 | −249M |
| FY2024 | 8.6M | +249.5% | −183M | -2,139.6% | -10.21 | −132M |
| FY2023 | 2.4M | – | −123M | -5,026.6% | -18.69 | −111M |
| FY2022 | 0.00 | – | −214M | –% | -69.65 | −185M |
| FY2021 | – | – | −167M | –% | -3.94 | −126M |
| FY2020 | – | – | −61.8M | –% | -7.86 | −52.6M |
| FY2019 | – | – | −35.5M | –% | -26.60 | −33.5M |